| IV-27 Hoai-Thu Thai Model-based drug development to support isatuximab dosing regimen selection in Phase II multiple myeloma patients Thursday 14:40-16:00 |
| IV-27 Hoai-Thu Thai Model-based drug development to support isatuximab dosing regimen selection in Phase II multiple myeloma patients Thursday 14:40-16:00 |